Co-Authors
This is a "connection" page, showing publications co-authored by Carl Lavie and Youssef Rizk.
Connection Strength
0.170
-
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. Drug Discov Today. 2021 02; 26(2):593-603.
Score: 0.057
-
Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs. 2020 Sep; 80(13):1267-1292.
Score: 0.056
-
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19". Drugs. 2020 09; 80(14):1501-1503.
Score: 0.056